Details for New Drug Application (NDA): 062306
✉ Email this page to a colleague
NDA 062306 describes PEDIAMYCIN, which is a drug marketed by Ross Labs and Arbor Pharms Llc and is included in three NDAs. Additional details are available on the PEDIAMYCIN profile page.
The generic ingredient in PEDIAMYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
The generic ingredient in PEDIAMYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Summary for 062306
| Tradename: | PEDIAMYCIN |
| Applicant: | Ross Labs |
| Ingredient: | erythromycin ethylsuccinate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062306
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 200MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
